News Alzinova AB

Equities

ALZ

SE0007413455

Market Closed - Nasdaq Stockholm Other stock markets 11:22:42 2024-04-26 am EDT			5-day change	1st Jan Change
1.156 ^SEK	-32.00%		-33.33%	-61.91%

Apr. 25	Sweden’s Alzinova Says CEO to Step Down by July-end	MT
Apr. 25	Kristina Torfgård Leaves the CEO Position At Alzinova Ab, Effective July 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NOTICE OF ANNUAL GENERAL MEETING IN ALZINOVA AB (PUBL)	Apr. 26	AQ
The Board of Directors resolves on a rights issue of shares of approximately SEK 34.4 million	Apr. 26	AQ
Sweden’s Alzinova Says CEO to Step Down by July-end	Apr. 25	MT
Kristina Torfgård leaves the CEO position at Alzinova AB in July 2024	Apr. 25	AQ
Kristina Torfgård Leaves the CEO Position At Alzinova Ab, Effective July 31, 2024	Apr. 25	CI
Alzinova: In-depth analysis shows positive trend in biomarkers	Apr. 11	AQ
Alzinova AB Completes In-Depth Analysis of Data from Part A of Alzinova's Phase 1B Study with the Vaccine Candidate ALZ-101	Apr. 11	CI
Alzinova - All patients in the extension part of the phase 1b study have received their last dose	Apr. 04	AQ
Alzinova AB Announces All Patients in the Extension Part of the Phase 1B Study Have Received Their Last Dose of ALZ-101	Apr. 04	CI
Sweden's Alzinova Names Interim CFO	Mar. 08	MT
Alzinova appoints Erik Kullgren as interim CFO	Mar. 08	AQ
Alzinova AB Announces CFO Changes	Mar. 08	CI
Alzinova presents at investor meetings in March	Mar. 05	AQ
Alzinova Q4 – With wind in the sails	Feb. 28	AQ
Alzinova publishes Year-end report 2023	Feb. 28	AQ
Alzinova AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Alzinova Secures Regulatory Approval to Test Higher Dose of Vaccine Candidate in Ongoing Trial	Feb. 13	MT
Alzinova receives regulatory approval to evaluate a higher dose	Feb. 13	AQ
Alzinova AB Receives Regulatory Approval to Evaluate A Higher Dose of the Vaccine Candidate Alz-101 in the Ongoing Phase 1B Study	Feb. 13	CI
SynAct Pharma Names New Chief Medical Officer	Feb. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alzinova AB

Equities

ALZ

SE0007413455

Summary

Filters